Search results
Merck Gambled With Keytruda In 2011 — How That Jump Is Still Paying Off Today
Investor's Business Daily· 2 years agoA gamble Merck made more than 10 years ago could pay off again for the pharmaceutical giant's stock...
Advanced Esophageal Cancer and Immunotherapy
Verywell Health via Yahoo News· 8 months agoA Newer Treatment OptionMedically reviewed by Gagandeep Brar, MD Immunotherapy for esophageal cancer is a newer treatment approach shown to improve the...
Moderna Stock Breaks Out As Cancer Vaccine Shows Promise In Keytruda Tie-Up
Investor's Business Daily· 1 year agoModerna stock broke out Tuesday after the company said adding its personalized cancer vaccine to...
How This New Merck Regimen Could 'Rewrite Textbooks' In Cancer Treatment — And Bolster 4 Stocks
Investor's Business Daily· 6 months agoMore than two-thirds of patients responded to an experimental bladder cancer treatment from Merck...
Personalized cancer vaccine results are a 'home run': Moderna CEO
Yahoo Finance via AOL· 1 year agoPreliminary results from a personalized cancer vaccine jointly studied by Moderna (MRNA) and Merck...
New Skin Cancer Vaccine Cuts Risk of Relapse by 44%, Study Shows—Here’s What to Know
Prevention via Yahoo News· 1 year agoA new vaccine has shown promise in reducing the risk of developing skin cancer. Phase 2 clinical...
Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return
Reuters via Yahoo News· 1 year agoAn experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or...
Mirati Therapeutics Crashes As The Cancer Rivalry With Amgen Heats Up
Investor's Business Daily· 1 year agoMirati Therapeutics said almost half of patients responded to its lung cancer regimen, but MRTX...
Moderna Stock Soars On 'Transformational' Potential Of Its Merck-Tied Cancer Vaccine
Investor's Business Daily· 4 months agoModerna's Merck-partnered cancer vaccine reduced the risk of relapse or death by 49% in melanoma...
The Surprising Way Mirati Therapeutics Is Angling To Rival Amgen — And Could Succeed
Investor's Business Daily· 2 years agoShares of MRTX stock rocketed Tuesday after Mirati Therapeutics unveiled early — but promising —...
